Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
  • Current Issue
  • Past Issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • 100th Anniversary of Insulin's Discovery (Jan 2021)
    • Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)
    • Latency in Infectious Disease (Jul 2020)
    • Immunotherapy in Hematological Cancers (Apr 2020)
    • Big Data's Future in Medicine (Feb 2020)
    • Mechanisms Underlying the Metabolic Syndrome (Oct 2019)
    • Reparative Immunology (Jul 2019)
    • View all review series ...
  • Viewpoint
  • Collections
    • Recently published
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • Recently published
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Alerts
  • Advertising/recruitment
  • Subscribe
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI
  • Top
  • Footnotes
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Corrigendum Free access | 10.1172/JCI86573

MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes

Mohit Sachdeva, Jeffrey K. Mito, Chang-Lung Lee, Minsi Zhang, Zhizhong Li, Rebecca D. Dodd, David Cason, Lixia Luo, Yan Ma, David Van Mater, Rebecca Gladdy, Dina C. Lev, Diana M. Cardona, and David G. Kirsch

Find articles by Sachdeva, M. in: JCI | PubMed | Google Scholar

Find articles by Mito, J. in: JCI | PubMed | Google Scholar

Find articles by Lee, C. in: JCI | PubMed | Google Scholar

Find articles by Zhang, M. in: JCI | PubMed | Google Scholar

Find articles by Li, Z. in: JCI | PubMed | Google Scholar

Find articles by Dodd, R. in: JCI | PubMed | Google Scholar

Find articles by Cason, D. in: JCI | PubMed | Google Scholar

Find articles by Luo, L. in: JCI | PubMed | Google Scholar

Find articles by Ma, Y. in: JCI | PubMed | Google Scholar

Find articles by Van Mater, D. in: JCI | PubMed | Google Scholar

Find articles by Gladdy, R. in: JCI | PubMed | Google Scholar

Find articles by Lev, D. in: JCI | PubMed | Google Scholar

Find articles by Cardona, D. in: JCI | PubMed | Google Scholar

Find articles by Kirsch, D. in: JCI | PubMed | Google Scholar

Published April 1, 2016 - More info

Published in Volume 126, Issue 4 on April 1, 2016
J Clin Invest. 2016;126(4):1606–1606. https://doi.org/10.1172/JCI86573.
Copyright © 2016, American Society for Clinical Investigation
Published April 1, 2016 - Version history
View PDF

Related article:

MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes
Mohit Sachdeva, … , Diana M. Cardona, David G. Kirsch
Mohit Sachdeva, … , Diana M. Cardona, David G. Kirsch
Corrigendum

MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes

  • Text
  • PDF
Abstract

Authors

Mohit Sachdeva, Jeffrey K. Mito, Chang-Lung Lee, Minsi Zhang, Zhizhong Li, Rebecca D. Dodd, David Cason, Lixia Luo, Yan Ma, David Van Mater, Rebecca Gladdy, Dina C. Lev, Diana M. Cardona, David G. Kirsch

×

Original citation: J Clin Invest. 2014;124(10):4305–4319. doi:10.1172/JCI77116.

Citation for this corrigendum: J Clin Invest. 2016;126(4):1606. doi:10.1172/JCI86573.

In the process of transferring the miR-182-flox and LSL-miR-182 mice to the Jackson Laboratory, the authors realized that the description of how the LSL-miR-182 mice were generated in the manuscript contained an error. Although the miR-182-flox mice were generated by crossing the mice to a flpO deleter strain to delete the Neo cassette, as was stated in the Methods section, the R26-LSL-miR-182 mice were not crossed to a deleter strain. Instead, the R26-LSL-miR-182 mice that were utilized in this work retained the Neo cassette. Two corrected sentences for the Methods section are below.

Chimeric males were mated to WT C57BL/6 females to generate heterozygotes. These mice were subsequently crossed to a flpO deleter strain to excise the frt-Neo-frt cassette to generate miR-182–flox mice.

The R26-LSL-miR-182 mice that were utilized in this work retained the Neo cassette.

The authors regret the error.

Footnotes

See the related article beginning on page 4305.

Version history
  • Version 1 (April 1, 2016): No description

Article tools

  • View PDF
  • Download citation information
  • Send a letter
  • Share this article
  • Terms of use
  • Standard abbreviations
  • Need Help? E-mail the JCI

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Footnotes
  • Version history
Advertisement
Advertisement
Follow JCI:
Copyright © 2021 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts